ACON Aclarion, Inc.
$2.60▲ +2.36%
Healthcare
Other
After hours
$2.60▲ +0.00%
Sep 11, 7:30 PM ET
Volume 17.7K
Avg Volume (10D) 48.0K
Key Metrics & Fundamentals
Market Cap
$7.49M
P/E Ratio
–
Div Yield
–%
52W Range
1.95 - 12.03
% vs 50 MA
3.58%
% vs 200 MA
-25.28%
RSI-14
56.3
MACD Histogram
+0.0200
Beta (1Y vs SPY)
1.08
Free Cash Flow
-$2.70M
Gross Rev
$25,208
Gross Profit
$8,297
EBITDA
-$2.84M
COGS
$16,911
Operating Exp
$2.91M
Operating Income
-$2.90M
EBIT
-$2.90M
Pretax Income
-$2.75M
Net Income
-$2.75M
EPS (Diluted)
-1.12
Price & Volume History
Loading chart…
Recent News
Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial Site
GlobeNewswire · Aug 20, 2026 11:00 AM
Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process
GlobeNewswire · Aug 12, 2026 11:00 AM
Aclarion, Inc. (ACON) Reports Q2 Loss, Lags Revenue Estimates
Zacks · Aug 6, 2026 4:00 PM
Sotera Health Company (SHC) Beats Q2 Earnings and Revenue Estimates
Zacks · Aug 6, 2026 1:50 PM
Aclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincent, First Site in Indiana to Offer the Technology
GlobeNewswire · Aug 4, 2026 11:00 AM
Aclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026
GlobeNewswire · Jul 29, 2026 11:00 AM
Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice
GlobeNewswire · Jul 21, 2026 11:00 AM
Aclarion Announces Texas Spine Care Center as New CLARITY Site
GlobeNewswire · Jul 7, 2026 11:00 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See ACON's money flow as a full page
Social Sentiment
Avg -0.60 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.